Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
TrendForce: This year is expected to be a key validation period for TSMC’s CoPoS equipment and materials, with glass substrates likely to enter mass production after 2030.

TrendForce: This year is expected to be a key validation period for TSMC’s CoPoS equipment and materials, with glass substrates likely to enter mass production after 2030.

金十金十2026/06/17 11:32
Show original
```htmlGolden Ten Data reported on June 17 that TrendForce's latest report indicates that TSMC is currently focused on CoPoS and targeting a substrate size of 310×310 mm. 2026 is expected to be a critical validation period for related equipment and material suppliers, with pilot production starting in 2027 and official mass production in the second half of 2028. In addition, TSMC's next stage of planning is expected to shift toward glass substrates, with mass production potentially commencing after 2030.```
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

From $617 to $350: CVS Sets "Break-Even Price" for Weight-Loss Drugs, Says Pharmaceutical Companies Can Still Profit

An analysis of insurance claims data found that if GLP-1 drugs used for weight loss and diabetes are priced below $350 per month, payers—such as employers and plan sponsors—would achieve net savings due to a decrease in related healthcare service utilization.

智通财经•2026/11/15 04:01
From $617 to $350: CVS Sets "Break-Even Price" for Weight-Loss Drugs, Says Pharmaceutical Companies Can Still Profit

UNI falls below $5

金色财经•2026/11/15 03:37
UNI falls below $5